SE8306882L - 7-karboximetoxifenylacetamido-3-cefem-derivat, forfaranden for framstellning derav och antibakteriella beredningar innehallande dem - Google Patents

7-karboximetoxifenylacetamido-3-cefem-derivat, forfaranden for framstellning derav och antibakteriella beredningar innehallande dem

Info

Publication number
SE8306882L
SE8306882L SE8306882A SE8306882A SE8306882L SE 8306882 L SE8306882 L SE 8306882L SE 8306882 A SE8306882 A SE 8306882A SE 8306882 A SE8306882 A SE 8306882A SE 8306882 L SE8306882 L SE 8306882L
Authority
SE
Sweden
Prior art keywords
substituted
carboximetoxifenylacetamido
procedures
preparing
preparations containing
Prior art date
Application number
SE8306882A
Other languages
English (en)
Swedish (sv)
Other versions
SE8306882D0 (sv
Inventor
Y Machida
S Negi
S Nomoto
T Kamiya
K Kitoh
I Saito
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP21772682A external-priority patent/JPS59108791A/ja
Priority claimed from JP3601783A external-priority patent/JPS59161389A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of SE8306882D0 publication Critical patent/SE8306882D0/xx
Publication of SE8306882L publication Critical patent/SE8306882L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
SE8306882A 1982-12-14 1983-12-13 7-karboximetoxifenylacetamido-3-cefem-derivat, forfaranden for framstellning derav och antibakteriella beredningar innehallande dem SE8306882L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21772682A JPS59108791A (ja) 1982-12-14 1982-12-14 7−カルボキシメトキシフエニルアセトアミド−3−セフエム誘導体、その製造方法およびそれからなる抗菌剤
JP3601783A JPS59161389A (ja) 1983-03-07 1983-03-07 7−カルボキシメトキシフエニルアセトアミドセフエム誘導体,その製造法およびそれからなる抗菌剤

Publications (2)

Publication Number Publication Date
SE8306882D0 SE8306882D0 (sv) 1983-12-13
SE8306882L true SE8306882L (sv) 1984-06-15

Family

ID=26375029

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8306882A SE8306882L (sv) 1982-12-14 1983-12-13 7-karboximetoxifenylacetamido-3-cefem-derivat, forfaranden for framstellning derav och antibakteriella beredningar innehallande dem

Country Status (16)

Country Link
US (1) US4546176A (it)
KR (1) KR840007012A (it)
AT (1) ATA435283A (it)
AU (1) AU2082783A (it)
BE (1) BE898442A (it)
CH (1) CH656131A5 (it)
DE (1) DE3345093A1 (it)
DK (1) DK572183A (it)
ES (2) ES528003A0 (it)
FR (1) FR2569195B1 (it)
GB (1) GB2132613B (it)
IT (1) IT1169969B (it)
NL (1) NL8304272A (it)
PH (1) PH20168A (it)
SE (1) SE8306882L (it)
YU (1) YU237283A (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
ATE193890T1 (de) * 1990-04-18 2000-06-15 Procter & Gamble Pharma Antimikrobielle chinolonyl-lactame
US5244892A (en) * 1990-10-16 1993-09-14 Kyorin Pharmaceutical Co., Ltd. Cephem compounds, and antibacterial agents
WO1996004286A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
WO1996004247A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making antimicrobial compounds
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
BRPI0408117A (pt) * 2003-03-05 2006-03-01 Rib X Pharmaceuticals Inc compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
US20070149463A1 (en) * 2003-10-30 2007-06-28 Oyelere Adegboyega K Bifunctional macrolide heterocyclic compounds and methods of making and using the same
EP1699808A1 (en) * 2003-11-18 2006-09-13 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP5383037B2 (ja) * 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208171A1 (es) * 1972-09-29 1976-12-09 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
SE8009049L (sv) * 1980-03-04 1981-09-05 Eisai Co Ltd 7alfa-metoxicefalosporinderivat, sett for framstellning derav och antibakteriella lekemedel innehallande dessa foreningar
US4468394A (en) * 1981-04-02 1984-08-28 Eisai Co., Ltd. Cephalosporin compounds

Also Published As

Publication number Publication date
GB2132613B (en) 1986-05-08
AU2082783A (en) 1984-06-21
FR2569195B1 (fr) 1987-01-09
DE3345093A1 (de) 1984-06-14
GB2132613A (en) 1984-07-11
IT8324122A0 (it) 1983-12-12
FR2569195A1 (fr) 1986-02-21
ES534297A0 (es) 1985-06-01
US4546176A (en) 1985-10-08
IT1169969B (it) 1987-06-03
YU237283A (en) 1986-04-30
GB8329554D0 (en) 1983-12-07
NL8304272A (nl) 1984-07-02
ES8506025A1 (es) 1985-06-16
ATA435283A (de) 1986-12-15
DK572183D0 (da) 1983-12-13
BE898442A (fr) 1984-06-13
KR840007012A (ko) 1984-12-04
SE8306882D0 (sv) 1983-12-13
CH656131A5 (de) 1986-06-13
DK572183A (da) 1984-06-27
ES528003A0 (es) 1985-06-16
PH20168A (en) 1986-10-09
ES8505691A1 (es) 1985-06-01

Similar Documents

Publication Publication Date Title
SE8306882L (sv) 7-karboximetoxifenylacetamido-3-cefem-derivat, forfaranden for framstellning derav och antibakteriella beredningar innehallande dem
JPS5746986A (en) Pyrido(1,2,3-de)(1,4)benzoxazine derivative
CA2096969A1 (en) 6-0-methylerythromycin a derivatives
SE8600193D0 (sv) Nya cefalosporiner
ES8704943A1 (es) Un procedimiento para la fabricacion de derivados de cefalosporina.
PT83423B (en) Process for preparation of new quinoline derivatives
ES8106310A1 (es) Un procedimiento para la preparacion de un compuesto de ce- falosporina
FI940011A0 (fi) Mono- ja bis-alkyyliaminoantrasykliinit
DE3170503D1 (en) 3-0-demethyl derivatives of istamycin b series compounds and their preparation
IE43346L (en) Cephalosporin derivatives.
DK206888A (da) Thiadiazolylacetamidcephemderivat
IE820238L (en) Carbapenem derivatives
SE7905520L (sv) Cefalosporinderivat
ES2014041A6 (es) Un procedimiento para preparar un derivado de amina.
FR2244514A1 (en) 1,2-Dihydroquinoline derivs - useful as anti-inflammatories
GB2009731A (en) Pyrido [3,2,1-jk] carbazol derivative
ES454469A1 (es) Un procedimiento de produccion de derivados de 7-(4-carboxi-butiramido)-7-metoxicefalosporina.
ES8200652A1 (es) Un procedimiento para la preparacion de 3-(3-metil-4-isopro-pilfenil)-1,1-dimetilurea
GB2010835A (en) I-Thiocyanato-8-substituted naphthalene derivatives
JPS56123989A (en) 7- n acylamino-alpha-arylacetamide -3- 1-substituted tetrazole- 5-ylthiomethyl cephalosporins

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8306882-5

Effective date: 19870416

Format of ref document f/p: F